| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.33 | 0.06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |